{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:23:21Z","timestamp":1790573001015,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jhep.2023.06.019","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T09:21:51Z","timestamp":1689499311000},"page":"1096-1109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2783-9300","authenticated-orcid":false,"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5883-9552","authenticated-orcid":false,"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A\u00a0proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"issue":"8","key":"10.1016\/j.jhep.2023.06.019_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"10290","key":"10.1016\/j.jhep.2023.06.019_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jhep.2023.06.019_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.jhep.2023.06.019_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jhep.2023.06.019_bib7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","article-title":"MicroRNAs in stress signaling and human disease","volume":"148","author":"Mendell","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.jhep.2023.06.019_bib9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"issue":"40","key":"10.1016\/j.jhep.2023.06.019_bib10","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1073\/pnas.1205951109","article-title":"Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor \u03b2-Klotho","volume":"109","author":"Fu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.06.019_bib11","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A\u00a0metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.06.019_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108642","article-title":"miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload","volume":"695","author":"Wang","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jhep.2023.06.019_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cmet.2016.01.014","article-title":"Paternal Psychological stress reprograms hepatic gluconeogenesis in offspring","volume":"23","author":"Wu","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.jhep.2023.06.019_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/JME-14-0127","article-title":"Aberrant miR199a-5p\/caveolin1\/PPAR\u03b1 axis in hepatic steatosis","volume":"53","author":"Li","year":"2014","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"16","key":"10.1016\/j.jhep.2023.06.019_bib16","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.7150\/thno.46882","article-title":"MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase","volume":"11","author":"Zheng","year":"2021","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.jhep.2023.06.019_bib17","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A\u00a0researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"issue":"9","key":"10.1016\/j.jhep.2023.06.019_bib18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","article-title":"Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis","volume":"4","author":"Zhou","year":"2022","journal-title":"Nat Metab"},{"issue":"20","key":"10.1016\/j.jhep.2023.06.019_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144801","article-title":"Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2","volume":"131","author":"Liu","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.06.019_bib20","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154229","article-title":"KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7","author":"Yang","year":"2022","journal-title":"EMBO Rep"},{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2023.06.019_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/febs.14349","article-title":"Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p\/SREBP-1c axis","volume":"285","author":"Zhong","year":"2018","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.jhep.2023.06.019_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ymthe.2019.09.013","article-title":"MicroRNA 223 3p negatively regulates the NLRP3 inflammasome in acute and chronic liver injury","volume":"28","author":"Jimenez Calvente","year":"2020","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.jhep.2023.06.019_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1039\/D0FO02286A","article-title":"The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL\/6N mice","volume":"12","author":"Pan","year":"2021","journal-title":"Food Funct"},{"issue":"6","key":"10.1016\/j.jhep.2023.06.019_bib25","article-title":"Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor","volume":"2","author":"Wang","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.06.019_bib26","article-title":"mmu-miR-145a-5p accelerates diabetic wound healing by promoting macrophage polarization toward the M2 phenotype","volume":"8","author":"Hao","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2023.06.019_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2019.12.013","article-title":"LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p\/KLF4\/myocardin axis","volume":"139","author":"Xu","year":"2020","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jhep.2023.06.019_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5276271","article-title":"miR-145a-5p promotes myoblast differentiation","volume":"2016","author":"Du","year":"2016","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.jhep.2023.06.019_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2016.05.057","article-title":"Methylation of miR-145a-5p promoter mediates adipocytes differentiation","volume":"475","author":"Du","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.jhep.2023.06.019_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/db16-1172","article-title":"NFE2 induces miR-423-5p to promote gluconeogenesis and hyperglycemia by repressing the hepatic FAM3A-ATP-akt pathway","volume":"66","author":"Yang","year":"2017","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.jhep.2023.06.019_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153640","article-title":"Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player","volume":"131","author":"Rodrigues","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.06.019_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.624122","article-title":"Role of the orphan nuclear receptor NR4A family in T-cell biology","volume":"11","author":"Odagiu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.jhep.2023.06.019_bib33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm1471","article-title":"NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism","volume":"12","author":"Pei","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jhep.2023.06.019_bib34","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101448R","article-title":"GBP5 promotes liver injury\u00a0and\u00a0inflammation by inducing hepatocyte apoptosis","volume":"36","author":"Ding","year":"2022","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.jhep.2023.06.019_bib35","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1053\/j.gastro.2021.02.051","article-title":"Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2023.06.019_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.yexmp.2011.07.001","article-title":"MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis","volume":"91","author":"Wanninger","year":"2011","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10.1016\/j.jhep.2023.06.019_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jhep.2023.06.019_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2017.11.054","article-title":"Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis","volume":"495","author":"Zhang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"51","key":"10.1016\/j.jhep.2023.06.019_bib39","doi-asserted-by":"crossref","first-page":"19795","DOI":"10.1074\/jbc.RA119.010730","article-title":"Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements","volume":"294","author":"Jiang","year":"2019","journal-title":"J\u00a0Biol Chem"},{"issue":"6590","key":"10.1016\/j.jhep.2023.06.019_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jhep.2023.06.019_bib41","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201475","article-title":"Hepatic Gadd45\u03b2 promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1\u03b1","volume":"218","author":"Wu","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.jhep.2023.06.019_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/ncb2867","article-title":"Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch","volume":"15","author":"Wang","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.jhep.2023.06.019_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect Clin Res"},{"issue":"18","key":"10.1016\/j.jhep.2023.06.019_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jhep.2023.06.019_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jhep.2023.06.019_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101119","article-title":"Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease","volume":"50","author":"Xiao","year":"2021","journal-title":"Mol Metab"},{"issue":"30","key":"10.1016\/j.jhep.2023.06.019_bib47","doi-asserted-by":"crossref","first-page":"18304","DOI":"10.1074\/jbc.M115.638064","article-title":"Nuclear receptor Nr4a2 promotes alternative polarization of macrophages and confers protection in sepsis","volume":"290","author":"Mahajan","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.06.019_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104640","article-title":"Nurr1 modulation mediates neuroprotective effects of statins","author":"Willems","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"10.1016\/j.jhep.2023.06.019_bib49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/ijo.2011.240","article-title":"The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss","volume":"36","author":"Veum","year":"2012","journal-title":"Int J Obes (Lond)"},{"issue":"23","key":"10.1016\/j.jhep.2023.06.019_bib50","doi-asserted-by":"crossref","first-page":"11299","DOI":"10.1073\/pnas.1902490116","article-title":"NURR1 activation in skeletal muscle controls systemic energy homeostasis","volume":"116","author":"Amoasii","year":"2019","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823049796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823049796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:49:30Z","timestamp":1759175370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823049796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0168827823049796"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.06.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}